| Codice | Descrizione | Confezione |
|---|---|---|
| RA0018-C.1 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone BCL2/782 (Concentrate) | 0.1 ml |
| RA0019-C.5 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone BCL2/796 (Concentrate) | 0.5 ml |
| RA0019-C.1 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone BCL2/796 (Concentrate) | 0.1 ml |
| RA0015-C.5 | Bcl-2 (Apoptosis and Follicular Lymphoma Marker); Clone 100/D5 (Concentrate) | 0.5 ml |
| RA0015-C.1 | Bcl-2 (Apoptosis and Follicular Lymphoma Marker); Clone 100/D5 (Concentrate) | 0.1 ml |
| RA0016-C.5 | Bcl-2 (Apoptosis and Follicular Lymphoma Marker); Clone 124 (Concentrate) | 0.5 ml |
| RA0016-C.1 | Bcl-2 (Apoptosis and Follicular Lymphoma Marker); Clone 124 (Concentrate) | 0.1 ml |
| ICS2003-25 | Bcl-2 Control Slides | 25 Slides |
| PDM016 | Bcl-2 Oncoprotein | 6ml |
| MOB130-05 | Bcl-2 Oncoprotein | 0.5ml |
| MOB130 | Bcl-2 Oncoprotein | 1ml |
| MOB005-05 | Bcl-2 Oncoprotein | 0.5ml |
| MOB005 | Bcl-2 Oncoprotein | 1ml |
| A00004.0025 | Bcl-2 Oncoprotein; Clone 124 | 25 ml |
| A00004 | Bcl-2 Oncoprotein; Clone 124 | 6 ml |
| A20004 | Bcl-2 Oncoprotein; Clone 124 | 2 ml |
| 60-0005-7 | Bcl-2, Antibody | 7 ml |
| 61-0005-5 | Bcl-2, Antibody | 0,5 ml |
| 61-0005-2 | Bcl-2, Antibody | 0,2 ml |
| 61-0005 | Bcl-2, Antibody | 1 ml |
| A00119-C | Bcl-2; Clone 100/D5 (Concentrate) | 1 ml |
| A00119-0025 | Bcl-2; Clone 100/D5 (Ready-To-Use) | 25 ml |
| A00119-0007 | Bcl-2; Clone 100/D5 (Ready-To-Use) | 7 ml |
| A00119-0002 | Bcl-2; Clone 100/D5 (Ready-To-Use) | 2 ml |
| AC-0242 | Bcl-6 | 1 ml |
| PDM229 | Bcl-6 (Follicular Lymphoma Marker) | 6 ml |
| PDM229-25 | Bcl-6 (Follicular Lymphoma Marker) | 25 ml |
| RA0024-C.5 | Bcl-6 (Follicular Lymphoma Marker); Clone IG191E/A8 (Concentrate) | 0.5 ml |
| RA0024-C.1 | Bcl-6 (Follicular Lymphoma Marker); Clone IG191E/A8 (Concentrate) | 0.1 ml |
| A20077 | Bcl-6; Clone PG-B6p | 2 ml |
| A00077.0025 | Bcl-6; Clone PG-B6p | 25 ml |
| A00077 | Bcl-6; Clone PG-B6p | 6 ml |
| RA0022-C.1 | Bcl-X (Apoptosis Marker); Clone 2H12 (Concentrate) | 0.1 ml |
| RA0022-C.5 | Bcl-X (Apoptosis Marker); Clone 2H12 (Concentrate) | 0.5 ml |
| RA0023-C.5 | Bcl-X (Apoptosis Marker); Clone BX006 & 2H12 (Concentrate) | 0.5 ml |
| RA0023-C.1 | Bcl-X (Apoptosis Marker); Clone BX006 & 2H12 (Concentrate) | 0.1 ml |
| RA0021-C.5 | Bcl-X (Apoptosis Marker); Clone BX006 (Concentrate) | 0.5 ml |
| RA0021-C.1 | Bcl-X (Apoptosis Marker); Clone BX006 (Concentrate) | 0.1 ml |
| RA0347-C.5 | BCL10 (MALT-Lymphoma Marker); Clone BL10/411 (Concentrate) | 0.5 ml |
| RA0347-C.1 | BCL10 (MALT-Lymphoma Marker); Clone BL10/411 (Concentrate) | 0.1 ml |
| 01946-25 | Benzil (Fotopolimerizzazione catalizzatore) | 25 g |
| 00425-10 | Benzoin etere metilico | 50 g |
| 00932-25 | Benzoin iso-propil etere | 25 g |
| 00425-10 | Benzoin metil etere (UV Catalizzatore) | 10 g |
| RA0424-C.5 | Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/1118 (Concentrate) | 0.5 ml |
| RA0425-C.5 | Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/961 (Concentrate) | 0.5 ml |
| RA0425-C.1 | Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/961 (Concentrate) | 0.1 ml |
| AC-0034 | Beta-Catenin | 1 ml |
| RP080-05 | Beta-Catenin | 0.5ml |
| RP080 | Beta-Catenin | 1ml |
